SMMT icon

Summit Therapeutics
SMMT

Overview Fund Trends Analyst Outlook Journalist POV

21 hedge funds and large institutions have $50.9M invested in Summit Therapeutics in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

1.42% more ownership

Funds ownership: 4.35% → 5.77% (+1.4%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$8.37M
2
+$1.83M
3
+$1.56M
4
PC
Polar Capital
United Kingdom
+$1.25M
5
HCM
Highbridge Capital Management
New York
+$1M

Top Sellers

1
-$103K
2
-$48.4K
3
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$20M
2
$10.1M
3
$3.55M
4
$3.03M
5
$2.65M
6
$2.19M
7
$1.83M
8
$1.27M
9
$1.25M
10
$1.15M
11
$1M
12
$968K
13
$628K
14
$618K
15
$465K
16
$40K
17
$31K
18
$19K
19
$3K
20
$3K
21
–